Infinity to Participate in Three Conferences in September
CAMBRIDGE, Mass. -- August 27, 2013
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in three
conferences during September. On September 3, 2013, Infinity will participate
in meetings at Citi’s 8^th Annual Biotech Conference in Boston, MA.
Additionally, Infinity will provide an overview of its business at the
*Morgan Stanley Global Healthcare Conference, New York City, September 9,
2013, 10:35 a.m. ET
*Stifel Healthcare Conference 2013, Boston, September 11, 2013, 9:45 a.m.
Live audio webcasts of Infinity’s presentations at the Morgan Stanley and
Stifel healthcare conferences will be accessible from the “Investors/Media”
section of the company's website, www.infi.com, and replays will be available
for 30 days following each event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to discovering,
developing and delivering best-in-class medicines to people with
difficult-to-treat diseases. Infinity combines proven scientific expertise
with a passion for developing novel small molecule drugs that target emerging
disease pathways. Infinity’s programs focused on the inhibition of
phosphoinositide-3-kinase and heat shock protein 90 are evidence of its
innovative approach to drug discovery and development. For more information on
Infinity, please refer to the company’s website at www.infi.com.
Infinity Pharmaceuticals, Inc.
Jaren Madden, 617-453-1336
Press spacebar to pause and continue. Press esc to stop.